Source: International Congress 2018 – Airway disease: recent discoveries
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Latorre (Pisa, Italy), V. Seccia (Pisa, Italy), M. Bartoli (Pisa, Italy), L. Cristofani-Mencacci (Pisa, Italy), M. Bradicich (Pisa, Italy), M. Daniele (Pisa, Italy), R. Del Cesta (Pisa, Italy), M. Miccoli (Pisa, Italy), S. Cianchetti (Pisa, Italy), E. Bacci (Pisa, Italy), P. Paggiaro (Pisa, Italy). Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma. 4422

Member's Comments

No comment yet.

Related content which might interest you: The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Impact of biologic therapy in severe asthma with nasal polyps Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Comparitive efficiency of different approaches to basic therapy of bronchial asthma of moderate form Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults Source: Eur Respir Rev 2014; 23: 510-518 Year: 2014 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 The way to improve the steroid sensitivity of target cells of patients with severe therapy resistant asthma Source: Eur Respir J 2006; 28: Suppl. 50, 313s Year: 2006 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 A new cause of difficult to treat asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Source: Eur Respir J 2001; 18: 439-441 Year: 2001 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma Source: Annual Congress 2008 - Asthma and inhalation injuries at work Year: 2008 Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Is it really time to look at distal airways to improve asthma phenotyping and treatment? Source: Eur Respir J 2011; 38: 1252-1254 Year: 2011 A difficult case: distinctions between difficult asthma, true severe asthma and overlap Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 The influence of different ways of steroid administration on the hemostasis parameters of bronchial asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 421s Year: 2003 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 A pragmatic guide to choosing biologic therapies in severe asthma Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 Year: 2021